TY - JOUR
T1 - Awareness of bone strength in patients with neuromuscular disorders
T2 - ERN EURO-NMD clinician survey and European patient survey
AU - Kruse, M. T.A.
AU - Olde Dubbelink, B. A.S.
AU - on behalf of the EURO-NMD Bone Strength Study Group
AU - Kroneman, M.
AU - de Groot, I.
AU - Schlüter, S.
AU - de Visser, M.
AU - Evangelista, T.
AU - Moretti, A.
AU - Weber, D.
AU - Ward, L. M.
AU - Voermans, N. C.
AU - D'Amico, A.
AU - Baets, J.
AU - Baumann, M.
AU - van der Beek, N.
AU - De Bleecker, J.
AU - Bruijnes, A.
AU - Claeys, K.
AU - Bruno, C.
AU - Dambrauskiene, M.
AU - D'Errico, E.
AU - Filosto, M.
AU - Gosk-Tomek, M.
AU - Herdewyn, S.
AU - Kornblum, C.
AU - Kostera-Pruszczyk, A.
AU - Maggi, L.
AU - Manganelli, F.
AU - Mueller-Felber, W.
AU - Munell, F.
AU - Nadaj-Pakleza, A.
AU - Nascimento, A.
AU - Olive, M.
AU - Ørstavik, K.
AU - Palmio, J.
AU - Pegoraro, E.
AU - Peterlin, B.
AU - van der Ploeg, A. T.
AU - Quijano-Roy, S.
AU - Remiche, G.
AU - Ricci, G.
AU - Rohlenová, M.
AU - Rosenbohm, A.
AU - Sacconi, S.
AU - Sansone, V.
AU - Santos, M.
AU - Schara-Schmidt, U.
AU - Servidei, S.
AU - Siciliano, G.
AU - Walter, M. C.
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/5/15
Y1 - 2025/5/15
N2 - Bone strength is reduced In various neuromuscular disorders (NMDs). We aimed to assess the awareness and practice of bone strength management in NDMs among clinicians and patients. We performed two online surveys; among health care providers (HCPs) of the European Reference Network for Neuromuscular Disorders (ERN EURO-NMD) and among patients. The survey among 52 HCPs showed that awareness of potentially impaired bone strength in people with NMDs was reasonable to good: the vast majority of HCPs asked often or almost always about bone fractures during history-taking (81 %). Bone strength was less often assessed: often or almost always at diagnosis (50 %) and at follow-up (58 %). Medical training on this topic was considered poor to very poor in 50 % of HCPs. Prevention and treatment of reduced bone strength was variable and multidisciplinary care was sub-optimal. The survey among 581 patients provided important additional insights. Many patients were followed-up outside ERN EURO-NMD centers and treatment was variable. These parallel surveys provided a broad view on the awareness and management of bone strength in people with NMDs. The findings are expected to increase the appreciation of this important aspect of NMD care, and direct future research foci and care guidelines.
AB - Bone strength is reduced In various neuromuscular disorders (NMDs). We aimed to assess the awareness and practice of bone strength management in NDMs among clinicians and patients. We performed two online surveys; among health care providers (HCPs) of the European Reference Network for Neuromuscular Disorders (ERN EURO-NMD) and among patients. The survey among 52 HCPs showed that awareness of potentially impaired bone strength in people with NMDs was reasonable to good: the vast majority of HCPs asked often or almost always about bone fractures during history-taking (81 %). Bone strength was less often assessed: often or almost always at diagnosis (50 %) and at follow-up (58 %). Medical training on this topic was considered poor to very poor in 50 % of HCPs. Prevention and treatment of reduced bone strength was variable and multidisciplinary care was sub-optimal. The survey among 581 patients provided important additional insights. Many patients were followed-up outside ERN EURO-NMD centers and treatment was variable. These parallel surveys provided a broad view on the awareness and management of bone strength in people with NMDs. The findings are expected to increase the appreciation of this important aspect of NMD care, and direct future research foci and care guidelines.
UR - http://www.scopus.com/inward/record.url?scp=105000801060&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2025.123420
DO - 10.1016/j.jns.2025.123420
M3 - Article
C2 - 40121805
AN - SCOPUS:105000801060
SN - 0022-510X
VL - 472
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 123420
ER -